Task-specific physical therapy for severe multiple sclerosis

The Effect of Task Specific Physical Therapy for Persons With Advanced Multiple Sclerosis

NA · Hunter College of City University of New York · NCT06506929

This study tests if a special type of physical therapy can help people with severe multiple sclerosis improve their ability to stand, balance, and move in bed.

Quick facts

PhaseNA
Study typeInterventional
Enrollment15 (estimated)
Ages18 Years to 75 Years
SexAll
SponsorHunter College of City University of New York (other)
Locations1 site (New York, New York)
Trial IDNCT06506929 on ClinicalTrials.gov

What this trial studies

This study investigates the feasibility, safety, and efficacy of task-specific physical therapy for individuals with severe multiple sclerosis (MS). Ten participants diagnosed with severe MS will engage in one-hour physical therapy sessions twice a week for six weeks, focusing on improving standing, balancing, and bed mobility. The study aims to provide a targeted approach to therapy, as previous research has primarily focused on individuals with mild to moderate MS. The findings will contribute to the understanding of effective treatments for those with severe disabilities due to MS.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals with a definitive diagnosis of multiple sclerosis and an Expanded Disability Status Scale (EDSS) score of 7.0-8.0.

Not a fit: Patients who have experienced an MS exacerbation in the four weeks prior to the study or have other conditions that interfere with participation may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide a new, effective physical therapy approach for patients with severe multiple sclerosis, improving their mobility and quality of life.

How similar studies have performed: Previous studies have shown the effectiveness of task-specific physical therapy in other neurological disorders, but this approach has not been extensively tested in individuals with severe MS.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. definitive diagnosis of Multiple Sclerosis
2. Expanded Disability Status Scale (EDSS) of 7.0-8.0
3. Ability to read, understand , and sign an informed consent -

Exclusion Criteria:

1. evidence of MS exacerbation in the 4 weeks prior to starting the study
2. any orthopedic, cardiopulmonary, or non-MS neurologic symptoms that will interfere with their ability to participate in the study

Where this trial is running

New York, New York

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Multiple Sclerosis

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.